Biomerica (BMRA) Enterprise Value (2010 - 2026)

Biomerica (BMRA) has 17 years of Enterprise Value data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 56.31% year-over-year to -$1.3 million; the trailing twelve-month figure through Feb 2026 stood at -$1.3 million (up 56.31% YoY), and the FY2025 full-year result was -$3.1 million, up 26.67% from the prior year.
• Enterprise Value climbed to -$1.3 million in Q1 2026, from -$2.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.3 million in Q1 2026 to a low of -$10.2 million in Q1 2022.
• A 5-year average of -$4.9 million and a median of -$4.2 million in 2024 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value slumped 92.96% in 2022 and soared 67.12% in 2023, its largest moves.
• Tracing BMRA's Enterprise Value over 5 years: stood at -$5.1 million in 2022, then tumbled by 40.81% to -$7.1 million in 2023, then surged by 66.75% to -$2.4 million in 2024, then slipped by 7.21% to -$2.5 million in 2025, then soared by 47.46% to -$1.3 million in 2026.
• Business Quant data shows BMRA's Enterprise Value at -$1.3 million in Q1 2026, -$2.5 million in Q4 2025, and -$3.1 million in Q3 2025.